EA
Emerald Advisers Portfolio holdings
AUM
$2.73B
1-Year Return
54.29%
This Quarter Return
+37.02%
1 Year Return
+54.29%
3 Year Return
+280.05%
5 Year Return
+497.66%
10 Year Return
+2,067.91%
AUM
$3.01B
AUM Growth
+$583M
(+24%)
Cap. Flow
+$11.6M
Cap. Flow
% of AUM
0.39%
Top 10 Holdings %
Top 10 Hldgs %
19.61%
Holding
374
New
40
Increased
94
Reduced
116
Closed
88
Top Buys
| 1 |
Ultragenyx Pharmaceutical
RARE
|
$31.4M |
| 2 |
Eastern Bankshares
EBC
|
$28.6M |
| 3 |
Ocular Therapeutix
OCUL
|
$24.6M |
| 4 |
CMD
Cantel Medical Corporation
CMD
|
$22.3M |
| 5 |
Arvinas
ARVN
|
$21.9M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$43.1M |
| 2 |
TopBuild
BLD
|
$39.8M |
| 3 |
Twist Bioscience
TWST
|
$36.7M |
| 4 |
QTS
QTS REALTY TRUST, INC.
QTS
|
$24.8M |
| 5 |
PS
Pluralsight, Inc. Class A Common Stock
PS
|
$24.1M |
Sector Composition
| 1 | Healthcare | 23.28% |
| 2 | Technology | 20.52% |
| 3 | Consumer Discretionary | 15.17% |
| 4 | Industrials | 13.7% |
| 5 | Financials | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
United Therapeutics
UTHR
$18.1B
| $32.3M | 1.07% |
212,954
+19,992
| +10% | +$3.03M |
|
27
Avient
AVNT
$3.45B
| $31.9M | 1.06% |
792,730
+218,364
| +38% | +$8.8M |
|
28
National Vision
EYE
$1.86B
| $31.7M | 1.05% |
700,987
+49
| +0% | +$2.22K |
|
29
Coherent
COHR
$15.2B
| $31.5M | 1.05% |
415,103
-724
| -0.2% | -$55K |
|
|
30
Ultragenyx Pharmaceutical
RARE
$3.07B
| $31.4M | 1.04% |
+226,875
| New | +$31.4M |
|
31
Five Below
FIVE
$8.46B
| $30.2M | 1% |
172,436
-16,885
| -9% | -$2.95M |
|
32
AtriCure
ATRC
$1.76B
| $29.8M | 0.99% |
536,099
+35,251
| +7% | +$1.96M |
|
33
LiveRamp
RAMP
$1.86B
| $28.9M | 0.96% |
395,290
+74,121
| +23% | +$5.42M |
|
|
CCXI
34
DELISTED
ChemoCentryx, Inc.
CCXI
| $28.7M | 0.95% |
463,961
+78,855
| +20% | +$4.88M |
|
|
35
Eastern Bankshares
EBC
$3.44B
| $28.6M | 0.95% |
+1,753,456
| New | +$28.6M |
|
36
Planet Fitness
PLNT
$8.77B
| $28.6M | 0.95% |
367,825
-93,075
| -20% | -$7.23M |
|
37
Karyopharm Therapeutics
KPTI
$57.2M
| $28.2M | 0.94% |
121,519
+14,635
| +14% | +$3.4M |
|
38
Q2 Holdings
QTWO
$4.92B
| $28.2M | 0.93% |
222,613
-927
| -0.4% | -$117K |
|
|
ARNA
39
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $28M | 0.93% |
364,392
+248,747
| +215% | +$19.1M |
|
40
Immunovant
IMVT
$2.99B
| $27.9M | 0.93% |
603,670
+62,606
| +12% | +$2.89M |
|
|
MODN
41
DELISTED
MODEL N, INC.
MODN
| $27.7M | 0.92% |
776,707
-10,162
| -1% | -$363K |
|
42
Yeti Holdings
YETI
$2.95B
| $26.6M | 0.88% |
389,114
+34
| +0% | +$2.33K |
|
43
Lattice Semiconductor
LSCC
$9.05B
| $26.5M | 0.88% |
578,415
+959
| +0.2% | +$43.9K |
|
44
Installed Building Products
IBP
$7.44B
| $25.7M | 0.85% |
252,456
-1,181
| -0.5% | -$120K |
|
|
AZEK
45
DELISTED
The AZEK Co
AZEK
| $25.4M | 0.84% |
660,904
+4,650
| +0.7% | +$179K |
|
46
Addus HomeCare
ADUS
$2.08B
| $25.1M | 0.83% |
214,548
+507
| +0.2% | +$59.4K |
|
47
Viavi Solutions
VIAV
$2.6B
| $24.9M | 0.83% |
1,660,296
-18,534
| -1% | -$278K |
|
|
48
Ocular Therapeutix
OCUL
$2.37B
| $24.6M | 0.82% |
+1,190,703
| New | +$24.6M |
|
49
Onto Innovation
ONTO
$5.1B
| $24.2M | 0.8% |
509,882
+160,113
| +46% | +$7.61M |
|
50
Semtech
SMTC
$5.26B
| $23.9M | 0.79% |
331,788
+46,294
| +16% | +$3.34M |
|